CM
Charles MakinHead of RWEBoehringer IngelheimHome › Past Editions › Boston 2026
Boston · USA East Coast EditionDelivered
RWE Connect Boston 2026
Evidence Evolution: RWE as the Foundation of Access, Value and Analytics. Two days, one track, and a room built from the people who commission, generate and assess real-world evidence.
Boston in Numbers
What Two Days in the Seaport Delivered
200+Delegates
23Speakers
19Sessions delivered
2Keynotes
2Panel discussions
5Sponsors and partners
Attendee Bifurcation
Who Was in the Room
The delegate profile across seniority, organisation type and geography.
By Seniority
By Organisation Type
By Region
Participating Organisations
The Companies That Came to Boston
Every organisation on stage at the inaugural edition. The delegate organisation list is added as it is cleared for publication.
Spoke or moderatedSponsored or partnered
AbbVie
Alcon
Apperture
Arcadia
Ariadne Labs
Azimuth Research Group
Bayer
Biogen
Boehringer Ingelheim
Cardio Diagnostics Holdings
Celcuity
CounterX Therapeutics
CSL Seqirus
Disc Medicine
Forian
Gilead Sciences
Main Character Health
Massachusetts College of Pharmacy and Health Sciences
Siemens Healthineers
UCB
Veloxis Pharmaceuticals
Truveta
Magnolia Market Access
Veritas Data Research
Delegate organisations to follow
Speakers
Who Took the Stage
Twenty-three speakers across keynotes, case studies and two panels, from global HEOR and RWE heads to the epidemiologists and data scientists who build the evidence.
LR
Leo RussoScientific AdvisorCounterX TherapeuticsMS
Mriga ShrikhandeHealth Economics and Outcomes Research ScientistCardio Diagnostics HoldingsTO
Tony OkoroGlobal Head, Health Economics and Outcomes Research, PharmaAlconCI
Chiemeka IkeHead, HEORCelcuityCD
Carissa DukesDirector, Global Epidemiology and RWEBoehringer IngelheimAP
Arup PramanikGlobal Head, HEOR and RWE, ImmunologyUCBJP
Jeanne PierzynskiAssociate Director, Real World Evidence OncologyGilead SciencesPM
Prajakta MasurkarHEOR Lead, US DermatologyUCBSC
Samantha C. RegisterVice President, Real-World StrategyAzimuth Research GroupIM
Ian McGovernAssociate DirectorCSL SeqirusDE
Dozie EmechebeAssociate Director, RWEAbbVieCC
Christabella CherubinoGlobal Medical Director, Medical LeadBiogenSP
Sonia PulgarFounder and CEOMain Character HealthKE
Ki-Do EumTechnical Lead, Data ScienceAriadne LabsLH
Lobat HashemiGlobal Head, HEOR, TransplantVeloxis PharmaceuticalsAT
Ashwini ThirugnanamPhD Candidate, PharmacoeconomicsMassachusetts College of Pharmacy and Health SciencesTL
Tianyu LiuResearch Intern, BiostatisticsSiemens HealthineersDR
Dhanish RevanthHEOR Consultant and EpidemiologistAppertureBK
Bashir KalayehNational Director, Health Economics and Outcomes ResearchBayerMK
Mahesh K. TawneyDirector, Strategic Accounts, EastDisc MedicineSL
Sandy LeonardGeneral Manager, Life SciencesArcadiaAA
Ashwin AnandAssociate Director, Client EngagementForianProgramme
The Sessions as Delivered
Session titles by day, with the four sponsor sessions marked. Timings and speaker notes are in the post-show report.
Day 1Evidence Evolution: RWE as the Foundation of Access, Value and Analytics
Demonstrating Drug Value: Outcomes Are the Currency, Evidence Is the BackboneKeynote
Magnolia Market Access sessionSponsor Session
Evolving RWE Frameworks From Regulatory and HTA Bodies
Tokenization in Practice: Unlocking Real-World Evidence While Protecting Patient Privacy
Evidence Generation in Rare Diseases
Veritas Data Research sessionSponsor Session
From Data Linkage to Decision Value: When Does Richer Real-World Data Improve the Decision?
From Evidence to Impact: Leveraging RWE to Influence Payers, Physicians, Patients and Regulators
Forian sessionSponsor Session
The Design and Interpretation of Real-World Evidence Studies, Causal Inference and Healthcare Analytics
Adjacency Between RWE, HEOR, AI and ValuePanel
Day 2Innovating With Intelligence: The Future of Life Science Analytics and Policy
Real-World Evidence: An Overlooked Value Driver for Life Sciences InvestorsKeynote
Presentation: Lobat Hashemi, Global Head, HEOR, Transplant, Veloxis Pharmaceuticals
Presentation: Ashwini Thirugnanam, Pharmacoeconomics Researcher, MCPHS
Arcadia sessionSponsor Session
Economics of Evidence: Quantifying the Value of RWE Across the Product Lifecycle
Predicting Cognitive Resilience Among the Oldest-Old Using Machine Learning: The Framingham Heart Study
The Strategic Case for Publicly Available Data in RWE Generation
From Evidence to Impact: Leveraging RWE to Influence Payers, Physicians, Patients and RegulatorsPanel
Video
Boston 2026 in Motion
The highlights film and short clips from the two days.
Video to come
Highlights FilmRWE Connect Boston 2026: Two Days in the Seaport
Opening Keynote: Outcomes Are the CurrencyDay 1 · Clip to come
Panel: Adjacency Between RWE, HEOR, AI and ValueDay 1 · Clip to come
One-to-One Meetings on the Exhibition FloorBoth days · Clip to come
Drinks Reception in the SeaportDay 1 · Clip to come
Photos
Boston in Pictures
Sessions, the exhibition floor, one-to-one meetings and the drinks reception. Placeholders stand in until the event photography is supplied.
Photo to comeOpening keynote, Day 1Photo to comeRegistration and networking breakfastPhoto to comePanel discussion on RWE, HEOR, AI and valuePhoto to comeOne-to-one meetingsPhoto to comePoster presentations over lunchPhoto to comeExhibition floorPhoto to comeRoundtable discussions, Day 2Photo to comeChairperson's opening, Day 2Photo to comeDrinks receptionPhoto to comeSponsor sessionPhoto to comeNetworking lunchPhoto to comeClosing remarks, Day 2
Sponsors and Partners
The Organisations That Backed Boston
Five organisations, from real-world data platforms to market access consultancies, took positions at the inaugural edition.
Sponsor Testimonials
What Sponsors Said Afterwards
“
Every meeting in our diary was with someone who owns an evidence budget. We closed two pilots that started as fifteen-minute conversations in Boston.
P
Head of Life Sciences PartnershipsPlatinum Sponsor
“
Our session was in the one track, so the whole room heard it. The questions afterwards told us exactly which accounts to follow up.
G
Managing DirectorGold Sponsor
“
A small room with the right people beats a large hall with the wrong ones. Boston was the former.
T
General Manager, Life SciencesThought Leadership Partner
Post-Show Report
Request the Boston 2026 Post-Show Report
The full record of the edition, sent as a PDF. Tell us who you are so that we can send the version that answers your question.